GSK plc ADR buy melinda
Start price
15.09.21
/
50%
€41.25
Target price
15.09.22
€43.75
Performance (%)
-16.61%
End price
15.08.22
€34.40
Summary
This prediction ended on 15.08.22 with a price of €34.40. The price of GSK plc ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.61%. melinda has a follow-up prediction for GSK plc ADR where he still thinks GSK plc ADR is a Buy. Dividends of €1.61 are taken into consideration when calculating the performance. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -3.141% | -3.141% | 10.119% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% |
According to melinda what are the pros and cons of GSK plc ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread GlaxoSmithKline plc ADR diskutieren
In the thread Trading GlaxoSmithKline plc ADR
Current prediction by melinda for GSK plc ADR
GSK plc ADR
Start price
Target price
Perf. (%)
€31.40
22.06.23
22.06.23
€35.00
22.06.24
22.06.24
21.08%
18.04.24
18.04.24
Could be worthwhile Investment >10% per year
